Andrew Norden, MD, MPH, MBA, is a neuro-oncologist and physician executive who serves as Chief Medical Officer of OncoHealth, the leading oncology specialist dedicated to helping health plans, employers, oncologists, and patients navigate the physical, mental, and financial complexities of cancer, where he leads clinical affairs and strategy. Dr. Norden previously served as Chief Medical Officer of COTA and Deputy Chief Health Officer and lead physician for oncology and genomics at IBM Watson Health. He is the author of more than 65 peer-reviewed papers, an Associate Editor of JCO-Clinical Cancer Informatics, and an active member of ASCO and the Society for Neuro-Oncology.
The notion that patients are always better off receiving treatment at academic centers is flawed, and when an employer offers a COE approach, it can mislead patients to choose that option when care in their local community may be more sensible.
The primary goal of incorporating RWE into clinical research isn’t to make RCTs unnecessary or irrelevant, but rather to better understand how drugs perform in broader patient groups, among other things.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.